DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

24.92 0.71 (2.93%)

Quote as of


company name or ticker

Recent Quotes

XLRN $24.92 2.93%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.19
Previous Close $24.21
Daily Range $23.87 - $25.04
52-Week Range $16.78 - $57.89
Market Cap $792.4M
P/E Ratio -4.70
Dividend (Yield) $0.00 (0.0%)
Volume 113,049
Average Daily Volume 151,007
Current FY EPS -$1.35

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary

3 Biggest Biotech Crashes in March

Here's why Celldex (CLDX), Acceleron (XLRN), and Newlink (NLNK) all tumbled in March.

Acceleron Pharma's (XLRN) CEO John Knopf on Q2 2014 Results - Earnings Call Transcript

Celgene's Pomalyst Data at European Hematology Association Shows Promise - Analyst Blog

3 Stocks Spiking on Unusual Volume

Acceleron Pharma (XLRN) John Knopf on Q1 2014 Results - Earnings Call Transcript

Stocks: Sheryl Sandberg Sells Shares of Facebook While Phillip Frost Buys Opko

Plus, sales at Acceleron Pharma and AEP Industries.

Acceleron Pharma (XLRN) Jumps: Stock Up 13.2% - Tale of the Tape

Why Tesla Motors, Acceleron Pharma, and Ballard Power Systems Jumped Today

The Dow finished just below its all-time highs, but the market's overall gains were small compared to these three stocks. Find out more about what made them soar.

Acceleron Pharma (XLRN) Falls: Stock Drops 5.7% in Session - Tale of the Tape

What You Ought To Know About Celgene's Deal-Making Magic

Celgene's investment team has made a string of savvy investments in early stage biotech companies.

See More XLRN News...